phenylalanine has been researched along with fosbretabulin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramanian, R; Fecik, RA; Raghavan, B; Sackett, DL; Steele, JC | 1 |
| Chen, X; Ci, T; Gu, Z; Jiang, J; Li, G; Shen, N; Tang, Z | 1 |
2 other study(ies) available for phenylalanine and fosbretabulin
| Article | Year |
|---|---|
Tubulysin analogs incorporating desmethyl and dimethyl tubuphenylalanine derivatives.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Female; Humans; Inhibitory Concentration 50; Models, Chemical; Oligopeptides; Ovarian Neoplasms; Phenylalanine; Stilbenes; Structure-Activity Relationship; Tubulin Modulators | 2008 |
Combretastatin A4 Nanodrug-Induced MMP9 Amplification Boosts Tumor-Selective Release of Doxorubicin Prodrug.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Doxorubicin; Drug Liberation; Female; Glutamic Acid; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Nanoparticles; Phenylalanine; Polyethylene Glycols; Prodrugs; Stilbenes; Tissue Distribution | 2019 |